Evaluation of the Pupil Dilation Reflex in Response to Noxious Stimulation in Anaesthetized Children. A Proof of Concept Trial

NCT ID: NCT03449732

Last Updated: 2022-05-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-30

Study Completion Date

2021-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

After conduction a pilot study, pupillary dilation reflex (PDR) is measured in response to nociceptive stimulation perioperatively in infants, children and adolescents.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

An infrared camera of the video pupillometer measures the pupillary dilation reflex (PDR) in response to incremental nociceptive stimuli. The PDR is a robust reflex, even in patients under general anesthesia, and may provide a potential evaluation of the autonomous nociceptive circuit. American Society of Anesthesiologists (ASA) classification I or II patients from the age of 28 days till 18 years undergoing elective surgery under general anesthesia are recruited. Enrolled patients perioperative undergo PDR measurement at 2 different standardized times (before and after opioid administration) generated by an inbuilt pupillary pain index (PPI) protocol. PPI, as a surrogate for nociception includes noxious stimulations from 10 up to 60 milli ampere (mA) until pupil dilation is larger than 13% from baseline diameter. Therefore, no inappropriate high stimulation is executed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Monitoring, Intraoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PDR measurement group A

Two measurements of PDR perioperatively before and after opioid administration in toddlers (28 days until 23 months)

Group Type EXPERIMENTAL

PDR measurement

Intervention Type DEVICE

PDR measurement at two standardized times perioperatively:

1. Anesthetized subject by sevoflurane sedation until a minimum alveolar concentration (MAC) of at least 1,5 is reached
2. Administration of fentanyl 2µg/kg, in the absence of adjustments in sedation depth

PDR measurement group B

Two measurements of PDR perioperatively before and after opioid administration in children (2 until 11 years)

Group Type EXPERIMENTAL

PDR measurement

Intervention Type DEVICE

PDR measurement at two standardized times perioperatively:

1. Anesthetized subject by sevoflurane sedation until a minimum alveolar concentration (MAC) of at least 1,5 is reached
2. Administration of fentanyl 2µg/kg, in the absence of adjustments in sedation depth

PDR measurement group C

Two measurements of PDR perioperatively before and after opioid administration in adolescents (12 until 18 years)

Group Type EXPERIMENTAL

PDR measurement

Intervention Type DEVICE

PDR measurement at two standardized times perioperatively:

1. Anesthetized subject by sevoflurane sedation until a minimum alveolar concentration (MAC) of at least 1,5 is reached
2. Administration of fentanyl 2µg/kg, in the absence of adjustments in sedation depth

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PDR measurement

PDR measurement at two standardized times perioperatively:

1. Anesthetized subject by sevoflurane sedation until a minimum alveolar concentration (MAC) of at least 1,5 is reached
2. Administration of fentanyl 2µg/kg, in the absence of adjustments in sedation depth

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PPI assessment

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Scheduled abdominal, urological or otorhinolaryngology surgery under general anaesthesia
* ASA I-II

Exclusion Criteria

* History of eye deformity, invasive ophthalmologic surgery
* Known cranial nerve(s) deficit
* Infection of the eye
* Predicted difficult airway management (Paediatric Difficult Airway Guidelines - Difficult Airway Society)
* Chronic opioid use (\>3 months)
* Ongoing treatment with beta-blockers, dopamine antagonists, topical atropine
* Preoperatively administrated benzodiazepins or antiemetics
Minimum Eligible Age

28 Days

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Antwerp

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Davina Wildemeersch

Principle investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nathalie Kegels, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Antwerp

Vera Saldien, MD

Role: STUDY_CHAIR

University Hospital, Antwerp

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University hospital Antwerp

Edegem, Antwerp, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17/46/519

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Safety and Efficacy Evaluation of S (+) - Ketamine in Children
NCT04834427 ENROLLING_BY_INVITATION PHASE4